Diseases

Pharmaceutical company ALK introduction of its sublingual allergy immunotherapy (SLIT) tablet ODACTRA set to be rolled out for US Patients in the age group of 18- 65 years afflicted…
Read More...

Omron Healthcare introduces an over the counter medical device, Avail for effective drug-free pain relief as millions of Americans suffer from alarming chronic pain Avail is Omron's…
Read More...

It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

Novaliq announces randomizing patients in its SEECASE Phase 2 clinical trial of NOV03 for treating dry eye disease. Novaliq is a pharmaceutical company delivering drugs that transforms…
Read More...

On having received $ 38 million Series A financing by Maxim Merchant Capital, Alveo technologies to embark on curation of efficient and cost-effective disease diagnostic devices aiding…
Read More...

Takeda Pharmaceuticals and Denali therapeutics asserted that they have collaborated to develop and commercialize up to three specified therapeutic product candidates for…
Read More...

Concentric Analgesics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to CA-008 for the treatment of post-surgical pain. CA-008 is a…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Avastin (bevacizumab) for the treatment of adults with…
Read More...

Lead Pharma announced that it has achieved a third milestone under its research collaboration with Sanofi, triggering an undisclosed milestone payment. The collaboration aims to develop…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved a new indication for Faslodex(fulvestrant), expanding the indication to include use with abemaciclib, a…
Read More...

Roche announced the launch of the DISCOVERY Teal HRP kit, the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell…
Read More...

Splunk Inc. announced biotechnology company Recursion Pharmaceuticals is using Splunk® Enterprise and the Splunk Machine Learning Toolkit to reach its goal of treating 100 molecular…
Read More...

Ionis Pharmaceuticals and Dynacure announced that Dynacure has licensed IONIS-DNM2-2.5Rx (Dyn101), a Generation 2.5 antisense drug targeting dynamin 2 for the treatment of centronuclear…
Read More...

Boehringer Ingelheim and MiNA Therapeutics (“MiNA”) announced that they have signed a collaboration and licensing agreement focused on the development of novel compounds to treat…
Read More...

Neurimmune announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for…
Read More...

In a small safety trial based on preclinical work by a Stanford researcher, participants receiving blood plasma infusions from young donors showed some evidence of improvement.…
Read More...

Exelixis announced that the U.S. Food and Drug Administration (FDA) has determined the company’s supplemental New Drug Application (sNDA) for CABOMETYX®(cabozantinib) for patients with…
Read More...

Flexion Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved Zilretta™ (triamcinolone acetonide extended-release injectable suspension), the first and only…
Read More...

Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative…
Read More...

AstraZeneca, along with MedImmune, its global biologics research and development arm, has announced that the European Medicines Agency (EMA) has accepted a Marketing…
Read More...